Some of the proteins that were highly significant and discriminatory in severe types of APS included LTA4H, NAMPT, TNFRSF21, TF, SULT4A1, which can potentially be used as biomarkers, both diagnostic, for risk stratification of APS, as well as therapeutic targets. This evidence concerns the gene SULT4A1 and autoimmune polyendocrinopathy.